ADAPY · Adaptimmune Therapeutics PLC
$0.03
+0.01 (+22.81%)
At close · Aug 28
Going-concern doubt
— flagged Aug 13, 2025
Substantial doubt about the company's ability to continue as a going concern.
“the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern within one year after the date the financial statements are issued.”View the 10-Q filed Aug 13, 2025
Market Cap
$44.53M
Shares
1.59B
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding ADAPY
2 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Defiance Nasdaq Junior Biotechnology ETF | — | 3,135 | $16,208 | 0.22% | Long | 2021-09-30 | |
| Guggenheim Active Allocation Fund | GUG | 273 | $2 | 0.00% | Long | 2026-05-29 |
Showing 1–2 of 2 positions